Abstract
AbstractMyocardial infarction (MI) remains the leading cause of death in patients with cardiovascular disease worldwide, with therapeutic approaches predominantly relying on medication, medical device implantation, and organ transplantation, each constrained by inherent limitations. Injectable hydrogels have recently emerged as promising therapeutic tools, noted for their biocompatibility, injectability, and capacity to provide mechanical support crucial for myocardial tissue repair. This review aims to comprehensively explore the interaction between injectable hydrogels and myocardial repair post‐infarction. It encompasses recent advancements in various types of injectable hydrogels used in MI therapy, including those modulating microenvironments, conducting electricity, influencing immunomodulation, promoting angiogenesis, and improving ischemia‐reperfusion conditions. By synthesizing current research findings, this review facilitates interdisciplinary knowledge integration and the development of effective prognostic indicators for injectable materials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
